Research programme: recombinant thyroid-stimulating hormone therapeutics - Trophogen
Latest Information Update: 22 Feb 2016
At a glance
- Originator Trophogen
- Class Diagnostic agents; Pituitary gonadotropins; Radiopharmaceutical diagnostics; Thyroid hormones
- Mechanism of Action Diagnostic imaging enhancers; Thyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Thyroid cancer
Most Recent Events
- 22 Feb 2016 Preclinical trials in Thyroid cancer in USA (unspecified route)
- 22 Feb 2016 Preclinical trials in Thyroid cancer (Diagnosis) in USA (unspecified route)